198 related articles for article (PubMed ID: 10745044)
1. Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder.
Mortier GR; Weis M; Nuytinck L; King LM; Wilkin DJ; De Paepe A; Lachman RS; Rimoin DL; Eyre DR; Cohn DH
J Med Genet; 2000 Apr; 37(4):263-71. PubMed ID: 10745044
[TBL] [Abstract][Full Text] [Related]
2. Substitution of aspartic acid for glycine at position 310 in type II collagen produces achondrogenesis II, and substitution of serine at position 805 produces hypochondrogenesis: analysis of genotype-phenotype relationships.
Bonaventure J; Cohen-Solal L; Ritvaniemi P; Van Maldergem L; Kadhom N; Delezoide AL; Maroteaux P; Prockop DJ; Ala-Kokko L
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):823-30. PubMed ID: 7741714
[TBL] [Abstract][Full Text] [Related]
3. A radiographic, morphologic, biochemical and molecular analysis of a case of achondrogenesis type II resulting from substitution for a glycine residue (Gly691-->Arg) in the type II collagen trimer.
Mortier GR; Wilkin DJ; Wilcox WR; Rimoin DL; Lachman RS; Eyre DR; Cohn DH
Hum Mol Genet; 1995 Feb; 4(2):285-8. PubMed ID: 7757081
[TBL] [Abstract][Full Text] [Related]
4. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type.
Tiller GE; Polumbo PA; Weis MA; Bogaert R; Lachman RS; Cohn DH; Rimoin DL; Eyre DR
Nat Genet; 1995 Sep; 11(1):87-9. PubMed ID: 7550321
[TBL] [Abstract][Full Text] [Related]
5. Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation.
Weis MA; Wilkin DJ; Kim HJ; Wilcox WR; Lachman RS; Rimoin DL; Cohn DH; Eyre DR
J Biol Chem; 1998 Feb; 273(8):4761-8. PubMed ID: 9468540
[TBL] [Abstract][Full Text] [Related]
6. The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene.
Hoornaert KP; Dewinter C; Vereecke I; Beemer FA; Courtens W; Fryer A; Fryssira H; Lees M; Müllner-Eidenböck A; Rimoin DL; Siderius L; Superti-Furga A; Temple K; Willems PJ; Zankl A; Zweier C; De Paepe A; Coucke P; Mortier GR
J Med Genet; 2006 May; 43(5):406-13. PubMed ID: 16155195
[TBL] [Abstract][Full Text] [Related]
7. An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita.
Tiller GE; Weis MA; Polumbo PA; Gruber HE; Rimoin DL; Cohn DH; Eyre DR
Am J Hum Genet; 1995 Feb; 56(2):388-95. PubMed ID: 7847372
[TBL] [Abstract][Full Text] [Related]
8. An alpha 1(II) Gly913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis.
Mundlos S; Chan D; McGill J; Bateman JF
Am J Med Genet; 1996 May; 63(1):129-36. PubMed ID: 8723098
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia.
Fernandes RJ; Wilkin DJ; Weis MA; Wilcox WR; Cohn DH; Rimoin DL; Eyre DR
Arch Biochem Biophys; 1998 Jul; 355(2):282-90. PubMed ID: 9675039
[TBL] [Abstract][Full Text] [Related]
10. Spondyloepiphyseal dysplasia congenita caused by double heterozygous mutations in COL2A1.
Kawano O; Nakamura A; Morikawa S; Uetake K; Ishizu K; Tajima T
Am J Med Genet A; 2015 Jul; 167(7):1578-81. PubMed ID: 25900302
[TBL] [Abstract][Full Text] [Related]
11. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita.
Unger S; Korkko J; Krakow D; Lachman RS; Rimoin DL; Cohn DH
Am J Med Genet; 2001 Nov; 104(2):140-6. PubMed ID: 11746045
[TBL] [Abstract][Full Text] [Related]
12. A Heterozygous Mutation in the Triple Helical Region of the Alpha 1 (II) Chain of the COL2A1 Protein Causes Non-Lethal Spondyloepiphyseal Dysplasia Congenita.
Almatrafi A; Alfadhli F; Khan YN; Afzal S; Hashmi JA; Ullah A; Albalawi AM; Basit S
Genet Test Mol Biomarkers; 2019 May; 23(5):310-315. PubMed ID: 30932712
[No Abstract] [Full Text] [Related]
13. An amino acid substitution (Gly853-->Glu) in the collagen alpha 1(II) chain produces hypochondrogenesis.
Bogaert R; Tiller GE; Weis MA; Gruber HE; Rimoin DL; Cohn DH; Eyre DR
J Biol Chem; 1992 Nov; 267(31):22522-6. PubMed ID: 1429602
[TBL] [Abstract][Full Text] [Related]
14. [Osteochondrodysplasia determined genetically by a collagen type II gene mutation].
Czarny-Ratajczak M; Rogala P; Wolnik-Brzozowska D; Latos-Bieleńska A
Chir Narzadow Ruchu Ortop Pol; 2001; 66(1):79-86. PubMed ID: 11481990
[TBL] [Abstract][Full Text] [Related]
15. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.
Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH
Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022
[TBL] [Abstract][Full Text] [Related]
16. The type II collagenopathies: a spectrum of chondrodysplasias.
Spranger J; Winterpacht A; Zabel B
Eur J Pediatr; 1994 Feb; 153(2):56-65. PubMed ID: 8157027
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of exon 12 of the COL2A1 gene interrupts the triple helix of type-II collagen in the Kniest form of spondyloepiphyseal dysplasia.
Chen L; Yang W; Cole WG
J Orthop Res; 1996 Sep; 14(5):712-21. PubMed ID: 8893763
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis.
Horton WA; Machado MA; Ellard J; Campbell D; Bartley J; Ramirez F; Vitale E; Lee B
Proc Natl Acad Sci U S A; 1992 May; 89(10):4583-7. PubMed ID: 1374906
[TBL] [Abstract][Full Text] [Related]
19. Radiologic Features of Type II and Type XI Collagenopathies.
Handa A; Grigelioniene G; Nishimura G
Radiographics; 2021; 41(1):192-209. PubMed ID: 33186059
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies.
Zankl A; Neumann L; Ignatius J; Nikkels P; Schrander-Stumpel C; Mortier G; Omran H; Wright M; Hilbert K; Bonafé L; Spranger J; Zabel B; Superti-Furga A
Am J Med Genet A; 2005 Feb; 133A(1):61-7. PubMed ID: 15643621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
